knowledge -WSS

knowledge

author：explore 2025-09-27 16:46:52 - browse：275

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Medical device lobby: We're tired of waiting on Medicare coverage

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Baby aspirin cuts fat buildup in liver disease patients, in small study

Physicians and social media: If you see something, say something?

U.K. researchers warn about biases in medical devices, algorithms

Methadone treatment changes are coming. Do they go far enough?

Argenx readies a blockbuster opportunity with drug for autoimmune disease

knowledge

knowledge

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

How to address the problem of discarded donor organs

Apple is now the first public company to be valued at $3 trillion

FogPharma raises $145 million in rare Series E round

As demand for Covid shots wanes, Moderna seeks its next success

Intermittent fasting comes with a heart risk? Not so fast

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congress gives doctors Medicare pay bump

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

RSV vaccines may be linked to small increased risk of developing GBS

explore

Stop the failed accountable care organization experiment

Gene editing the human germline: What are the risks?

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Argenx readies a blockbuster opportunity with drug for autoimmune disease

ALS groups 'won't be played again' by the FDA, drug sponsors

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

focus

focus

hotspot